Antineutrophil Cytoplasmic Antibodies associated vasculitis in Patients with Tuberculosis
Main Article Content
Abstract
A sixty-five-year-old female was diagnosed disseminated tuberculosis (TB) infection. Two weeks after initiating TB treatment, she developed rapid progressive glomerulonephritis, polyneuropathy, active alveolitis, peripheral ulcerative keratitis (PUK), and episcleritis. Positivity of a high level of anti-Myeloperoxidase (MPO) Antibody, which is compatible with antineutrophil cytoplasmic antibodies-associated vasculitis. After receiving monthly intravenous immunoglobulin (IVIG) treatment and concurrent steroid therapy alongside anti-tuberculosis drugs, her clinical condition improved.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
(ใส่ข้อความเดียวกันกับ ก๊อปปี้ไลน์ก็ได้)ดูตัวอย่างได้ที่หน้าบทความ---บทความนี้ตีพิมพ์เป็นลิขสิทธื์ของใคร...
References
Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B, Marmiesse M, et al. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog. 2005;1(1):e5.
Hershkovitz I, Donoghue HD, Minnikin DE, Besra GS, Lee OY, Gernaey AM, et al. Detection and molecular characterization of 9,000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean. PLoS One. 2008;3(10):e3426.
Pradhan VD, Badakere SS, Ghosh K, Pawar AR. Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis overlaps with that of Wegener's granulomatosis. Indian J Med Sci. 2004;58(7):283-8.
Martínez-Martínez MU, Gómez-Gómez A, Oros-Ovalle C, Abud-Mendoza C. A male patient with cavitary pulmonary disease. Reumatol Clin. 2013;9(1):62-4.
Schmitt WH, van der Woude FJ. Clinical applications of antineutrophil cytoplasmic antibody testing. Curr Opin Rheumatol. 2004;16(1):9-17.
Bossuyt X, Cohen Tervaert J-W, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin L, et al. Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nature Reviews Rheumatology. 2017;13(11):683-92.
Sherkat R, Mostafavizadeh K, Zeydabadi L, Shoaei P, Rostami S. Antineutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis. Iran J Immunol. 2011;8(1):52-7.
Carvalho M, Dominoni RL, Senchechen D, Fernandes AF, Burigo IP, Doubrawa E. Cutaneous leukocytoclastic vasculitis accompanied by pulmonary tuberculosis. J Bras Pneumol. 2008;34(9):745-8.
Esquivel-Valerio JA, Flores-Suárez LF, Rodríguez-Amado J, Garza-Elizondo MA, Rendón A, Salinas-Carmona MC. Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation. Clin Exp Rheumatol. 2010;28(1 Suppl 57):35-9.
Kakoullis L, Parperis K, Papachristodoulou E, Panos G. Infection-induced myeloperoxidase specific antineutrophil cytoplasmic antibody (MPO-ANCA) associated vasculitis: a systematic review. Clinical Immunology. 2020;220:108595.
Teixeira L, Mahr A, Jaureguy F, Noël LH, Nunes H, Lefort A, et al. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis. Rheumatology (Oxford). 2005;44(2):247-50.
Tan CD, Smith A, Rodriguez ER. Systemic necrotizing vasculitis induced by isoniazid. Cardiovascular Pathology. 2014;23(3):181-2.
Ji G, Zeng X, Sandford AJ, He JQ. Rifampicin-induced antineutrophil cytoplasmic antibody-positive vasculitis: a case report and review of the literature. Int J Clin Pharmacol Ther. 2016;54(10):804-7.
Ogata H, Kubo M, Tamaki K, Hirakata H, Okuda S, Fujishima M. Crescentic Glomerulonephritis due to Rifampin Treatment in a Patient with Pulmonary Atypical Mycobacteriosis. Nephron. 1998;78(3):319-22.